Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

ULTACAN

ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE

Standard Dose
4%;EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ULTACAN is listed in Drugs@FDA under application 201751 (ANDA).

Marketing status: Discontinued Active ingredient ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE Form and strength INJECTABLE;INJECTION - 4%;EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML) Sponsor HANSAMED INC Submission history Latest submission status date: 2017-07-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview ULTACAN is listed in Drugs@FDA under application 201751 (ANDA). Marketing status: Discontinued Active ingredient ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE Form and strength INJECTABLE;INJECTION - 4%;EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML) Sponsor HANSAMED INC Submission history Latest submission status date: 2017-07-11 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.